Yoshida et al. found that RBCs from patients with Alzheimer’s disease have elevated levels of oxidized Prx2, indicating that it is a potential biomarker for the early detection of Alzheimer’s disease [14]. This evidence concerns the gene PRRX2 and Alzheimer disease.